Safety and activity of CLN-081 (TAS6417) in NSCLC with EGFR Exon 20 insertion mutations (Ins20).
Zofia Piotrowska,Helena Alexandra Yu,James Chih-Hsin Yang,Marianna Koczywas,Egbert F. Smit,Daniel Shao-Weng Tan,Victor Ho-Fun Lee,Ross A. Soo,John M. Wrangle,Alexander I. Spira,Vamsidhar Velcheti,Mark A. Socinski,Asher Page,David Witter,Leigh Zawel,Jon M. Wigginton, Myles Steven Clancy,Danny Nguyen JOURNAL OF CLINICAL ONCOLOGY（2021）
AI 理解论文
溯源树
样例
